TDM for Optimized Outcome in Patients With mRCC. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TDM for Optimized Outcome in Patients With mRCC. — Stella

Home/Kidney Cancer/

View on ClinicalTrials.gov

Recruiting

Back to Kidney Cancer trials

Trial locations(1 site)

Denmark

Department of Oncology, Aarhus University Hospital, Aarhus, Danmark

Key details

Sponsor

Niels Fristrup

Collaborators

Herlev Hospital, Rigshospitalet, Denmark

Enrollment target

~200 participants

Started

November 2020

Primary completion

August 2028

Age range

18 Years and older

Last updated March 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.